Luminera Derm
Injectable Beauty Solutions
Startup Acquired Health Tech & Life Sciences Est. 2013 Acquired
Total Raised
Undisclosed
Acquired
Last Round
Undisclosed
Team
2
11-50 employees
Confidence
92/100
News
2
articles
Patents
1
About
Luminera Derm is an R&D company and manufacturer of injectable medical devices in the field of aesthetic medicine. Crystalys is a calcium hydroxyapatite-based injectable dermal filler designed to restore facial volume and natural contours by promoting generation and deposition of natural collagen, the body's physiological soft-tissue filler. HArmonyCa is designed to restore facial volume and correct facial deficiencies by promoting the generation of natural endogenous collagen. Hydryalix is a sterile, transparent, cross-linked hyaluronic acid injectable filler. Hydryal is an injectable, non-cross-linked hyaluronic acid clear gel, designed to enhance skin hydration and restore skin vitality. All Luminera products strictly comply with ISO9001 and ISO13485 standards.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesLife SciencesCosmeticsConsumersRecreational & Lifestyle
Business Model
B2CB2B
Tags
anti-agingcosmeticsskin-carepatientswellnesspharmaceuticalsconsumers
Funding & Events
Oct 2020
Exit Undisclosed
News (2)
Oct 18, 2020 · en.globes.co.il
growth-positive
Looking $100 million
AcquisitionExpand
Oct 8, 2020 · en.globes.co.il
growth-positive
AbbVie buys Israeli aesthetic medicine co Luminera
Acquisition
Details
Product Stage
Released
Employees
11-50
Exact Count
22
District
Center District
Founded
2013
Registrar
514882802
Crunchbase
luminera-pharm-ltd
Locations
Bat Sheva Street 1, Lod, Israel
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Sep 6, 2024
Verified by
Natalia Golczar
Missing
funding rounds, markets, not claimed
Team (2)
Yaron Levy
CFO
Eran Goldberg
CTO
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2017-06-29T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wain@gmail.com)
Status
Acquired by Allergan Aesthetics on Oct, 2020